Bristol-Myers Squibb to Present Data at 2015 American Society of Clinical Oncology from its Broad Immuno-Oncology Portfolio Across Solid Tumors (Last Night)
May 14, 2015 at 07:56 AM EDT
Bristol-Myers Squibb Company (NYSE: BMY) today announced new clinical research from three of its Immuno-Oncology agents will be ...
